![Eva-Lotta Allan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eva-Lotta Allan
Director/Board Member at
ALMIRALL, S.A.
Net worth: 39 750 $ as of 2026-07-30
Profile
Ms. Eva-Lotta Allan is a Non-Executive Chairman at Maxion Therapeutics Ltd., a Non-Executive Chairman at Draupnir Bio ApS and an Independent Non-Executive Director at Almirall SA. She is on the Board of Directors at Zelluna ASA, Almirall SA and Zelluna Immunotherapy AS.
Ms. Allan was previously employed as a Non-Executive Director by Aleta Biotherapeutics, Inc., a Non-Executive Chairman by C4X Discovery Holdings Ltd., a Non-Executive Director by Crescendo Biologics Ltd., an Independent Director by Targovax ASA, a Director & Chief Business Officer by Immunocore Holdings Ltd., a Chief Business Officer by Ablynx NV, a Senior Director-Global Business Development by Vertex Pharmaceuticals (Europe) Ltd., a Principal by GE Healthcare Ltd. (United Kingdom), a Principal by Karolinska Institutet, a Principal by Oxford Asymmetry International Plc, and a Principal by Oxford GlycoSciences Plc.
She also served on the board at Novavax AB and The Bioindustry Association.
She received her undergraduate degree from the University of Stockholm.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.06% | 2025-12-30 | 16,250 ( 0.06% ) | 39 750 $ | 2026-07-30 |
Eva-Lotta Allan active positions
| Companies | Position | Start |
|---|---|---|
| ALMIRALL, S.A. | Director/Board Member | 2020-06-30 |
Maxion Therapeutics Ltd.
 Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Chairman | 2023-09-20 |
Draupnir Bio ApS
 Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Chairman | 2021-05-31 |
Zelluna Immunotherapy AS
 Zelluna Immunotherapy AS BiotechnologyHealth Technology Engages in development of off the shelf T-cell receptor natural killer cell therapies | Director/Board Member | - |
Former positions of Eva-Lotta Allan
| Companies | Position | End |
|---|---|---|
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell therapy solutions for cancers and transforms cellular therapeutics to allow a broader spectrum of cancer indications | Director/Board Member | 2024-10-31 |
| C4X DISCOVERY HOLDINGS PLC | Chairman | 2023-06-19 |
| CIRCIO HOLDING ASA | Director/Board Member | 2023-04-30 |
| IMMUNOCORE HOLDINGS PLC | Director/Board Member | 2018-03-31 |
| ABLYNX | Public Communications Contact | 2010-05-03 |
Training of Eva-Lotta Allan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Almirall SA
 Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Asymmetry International Plc
 Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Process Industries |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Developes and manufactures novel products for the diagnosis and treatment of human disease | Health Technology |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Develops, manufactures, and sells vaccine adjuvants | Health Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Pharmaceuticals (Europe) Ltd.
 Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Supplies pharmaceutical products | Distribution Services |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Commercial Services |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Commercial Services |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
C4X Discovery Holdings Plc
 C4X Discovery Holdings Plc Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
Zelluna Immunotherapy AS
Zelluna Immunotherapy AS BiotechnologyHealth Technology Engages in development of off the shelf T-cell receptor natural killer cell therapies | Health Technology |
Aleta Biotherapeutics, Inc.
Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell therapy solutions for cancers and transforms cellular therapeutics to allow a broader spectrum of cancer indications | Commercial Services |
Draupnir Bio ApS
Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Health Technology |
- Stock Market
- Insiders
- Eva-Lotta Allan
